MA, FRCP (Paeds, UK), PhD, FRCPath
Associate Professor of Haematology and Transfusion Medicine
- Consultant Haematologist
Clinical indications of blood components, through systematic reviews and clinical studies/trials.
Dr Simon Stanworth is a Consultant Haematologist for NHSBT at the John Radcliffe Hospital (Oxford University Hospitals Foundation Trust), and honorary senior clinical lecturer at the University of Oxford. He has over 15 years of clinical research experience since gaining his PhD in 1995 from the University of Oxford. His research is centred on clinical indications of blood transfusion components, through systematic reviews and clinical studies/trials. Highlights have included several international randomised trials published in NEJM. He has published extensively, having over 150 peer-reviewed research articles, with an h-index 48; more recently he has been involved with 5 national guidelines. He is secretary of the South Central Regional Transfusion Committee. Dr Stanworth is a current scientific member of the BEST Collaborative from 2007.
Relationship between anaemia, coagulation parameters during pregnancy and postpartum haemorrhage at childbirth: a prospective cohort study
NAIR M. et al, (2021), BMJ Open
Under-recognised burden of postoperative anaemia in patients undergoing emergency abdominal surgery in the UK
Kanga K. et al, (2021), British Journal of Anaesthesia, 127, e105 - e108
Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference.
Spinella PC. et al, (2021), The journal of trauma and acute care surgery, 91, S19 - S25
Expected individual benefit of prophylactic platelet transfusions in hemato-oncology patients based on bleeding risks.
Cornelissen LL. et al, (2021), Transfusion
Editorial: Hemostatic Challenges in Pediatric Critical Care Medicine
Crighton GL. et al, (2021), Frontiers in Pediatrics, 9